Product Images Metoprolol Succinate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Metoprolol Succinate NDC 71335-2435 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure - figure001

Figure - figure001

This text provides information on the results of a study called MERIT-HF, focusing on the total mortality and hospitalization outcomes for heart failure patients treated with Wetoprolol Succinate Extended-Release tablets compared to a placebo. The study looked at various subgroups including NYHA class, ejection fraction, ischemic etiology, sex, race, previous medical history such as myocardial infarction, diabetes, and hypertension. It also includes mean heart rates for different subgroups. The study indicates favorable outcomes for Wetoprolol Succinate in certain subgroups. Key terms include US (United States), NYHA (New York Heart Association), EF (ejection fraction), and HR (heart rate).*

Label - lbl713352435

Label - lbl713352435

Each extended-release tablet contains 95 mg of Metoprolol Succinate equivalent to 100 mg of Metoprolol Tartrate, USP. This package is child-resistant and contains 30 tablets. It should be stored at 20° to 25°C (68° to 77°F) in a tight, light-resistant container. The tablets are only available by prescription and should be kept out of reach of children. For more information and details, visit https://dailymed.nlm.nih.gov/dailymed/*

Structure - structure001

Structure - structure001

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.